Véronique Moulin

Blood versus lymphatic endothelial cells: different responses for different roles financé du 2025-04-01 au 2030-03-31

Toward a combined gene therapy and tissue engineering novel treatment for junctional epidermolysis bullosa financé du 2025-04-01 au 2028-03-31

Clinical trial for dystrophic epidermolysis bullosa (EB) using GMEB-SASS, a genetically modified EB skin substitute financé du 2025-04-01 au 2028-03-31

A cGMP facility for personalized tissue engineering financé du 2024-12-01 au 2027-12-31

The implication of PlGF in cutaneous fibrosis financé du 2022-10-01 au 2027-09-30

Real World Clinical and Economic Burden of Severe Burn Injuries financé du 2023-10-01 au 2026-09-30

Tissue engineering to treat Canadian burn patients: the Self-Assembled Skin Substitutes (SASS) financé du 2022-04-01 au 2026-01-31

Allogeneic dermis to accelerate the production of a tissue-engineered skin substitute to treat Canadian burn patients financé du 2023-04-01 au 2025-07-31

Centre du génie tissulaire (CHU de Québec - Université Laval) financé du 2019-04-01 au 2025-03-31

Action des microvésicules dans les tissus solides financé du 2019-04-01 au 2025-03-31

Combining tissue-engineered skin with ex vivo gene therapy correction to develop a treatment for epidermolysis bullosa financé du 2022-04-01 au 2025-01-31

Cryo-TEM infrastructure for the visualisation of nanoparticles, exosomes and virus-like particles financé du 2023-03-31 au 2024-03-31

Mise au point par génie tissulaire d'un modèle de cicatrisation cutanée contenant des cellules immunitaires financé du 2019-01-27 au 2024-02-29

Setting up the conditions for the biobanking of tissues and cells from hypertrophic scars financé du 2022-12-01 au 2024-02-28